Infection Clinical Trial
Official title:
Effects of Applying Powdered Prophylactics Verses Intravenous Antibiotics Only on Post-operative Infection Rate
Hypothesis: Directly applying antibiotic powder onto the site of surgery along with perioperative intravenous antibiotics, before closing the wound, is more effective than intravenously applied perioperative antibiotics alone in controlling post-operative wound infection. The investigators also think powders that control both gram positive and gram negative bacteria are more beneficial.
1. Subjects will be divided into three groups based on the procedure used for the
application of antibiotics
1. No local antibiotics (control group): In this group, individuals will be subjected
to peri-operative intravenous* antibiotics only
2. Gram positive antibiotic: In this group, gram positive (powdered vancomycin)+ will
be applied to the site of surgery, before closure of the wound, along with
peri-operative intravenous antibiotics*
3. Gram positive and gram negative: In this group, gram positive (powdered
vancomycin) will be instilled on the site of surgery, before closing the wound,
and gram negative antibiotic (gentamycin mixed with bone cement)+ will be used,
along with peri-operative intravenous antibiotics* (only in cases of implant
fixation).
- Intravenous antibiotic dosage: 1 pre-operative dose of Cefuroxime 1.5 gm and
2 post-operative doses of Cefuroxime 750 mg.
- Vancomycin and Gentamycin dosage: 500 mg of vancomycin powder will be
used and in group 'c' gentamycin mixed with bone cement will be used
along with vancomycin powder.
2. Sample size: Based on, finding at least 4% difference between the proportions of
infections found in control (generally 5%, 4% in case of joint replacement) and case
groups (1%) (proportions were assumed from literature and our institute records), a
sample size of minimum 285 in each group (424 for joint replacement cases) will be
considered for the observation to be significant at an alpha level of 0.05. This will
give the study a minimum power of 80%.
Spine cases: Control = 143, Gram-P = 143; Trauma cases: Control = 143, Gram-P = 143;
Joint replacement cases: Control = 424, Gram-P = 424, Gram-P+Gram-N = 424; Total =
1844; Where Control - Cases with intravenous antibiotic dose; Gram-P - Cases with
intravenous antibiotic + local antibiotic (Vancomycin, acts against gram positive
bacteria); Gram-N - Cases with intravenous antibiotic + local antibiotic (Vancomycin,
acts against gram positive bacteria) + local Gentamycin cement (acts against gram
negative bacteria).
3. Procedure: Sampling will be based on stratified procedure. The total sample will be
divided into categories based on the type of surgery, which are spine, trauma and joint
replacement. Subjects within each category will be randomly selected for the three
antibiotic treatments. For this study, we will use computer software to generate
restricted randomization to achieve balance between groups in size. Within this
restricted randomization, single block random size will be used to ensure randomization
within each group.
While joint surgery category will have all the three groups of cases (a, b and c),
spine and trauma surgery category will have only two groups (a and b). Surgeries will
be performed accordingly i.e. control group individuals will undergo mandated hospital
policy requirements + perioperative intravenous antibiotic treatment and cases will
undergo mandated hospital policy requirements + powdered vancomycin, or both
vancomycin, just before the closure of the wound, and gentamycin as a mix with bone
cement. Patients who exhibit both superficial and deep wood infection will be
considered as infected and accounted for statistical analysis.
4. Analysis: Our main parameter of comparison is infection percentage among control and
cases. Various factors like duration of surgery, tourniquet time, prior infections,
blood transfusion, haemoglobin count, comorbidities, etc, will be considered while
analysing for infection percentage. Infection proportions will be compared between
different groups at a significance level of 0.05.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04529421 -
Assocation Between In-person Instruction and COVID-19 Risk
|
||
| Recruiting |
NCT04081792 -
Optimal Antibiotics for Operated Diabetic Foot Infections
|
N/A | |
| Completed |
NCT04332861 -
Evaluation of Infection in Obstructing Urolithiasis
|
||
| Recruiting |
NCT04674657 -
Does Extra-Corporeal Membrane Oxygenation Alter Antiinfectives Therapy Pharmacokinetics in Critically Ill Patients
|
||
| Enrolling by invitation |
NCT05052203 -
Researching the Effects of Sepsis on Quality Of Life, Vitality, Epigenome and Gene Expression During RecoverY From Sepsis
|
||
| Recruiting |
NCT00342589 -
New Techniques for Using a Saline Wash as a Diagnostic Tool for Pneumocystis Pneumonia
|
||
| Completed |
NCT03295825 -
Heparin Binding Protein in Early Sepsis Diagnosis
|
N/A | |
| Completed |
NCT03296423 -
Bacillus Calmette-guérin Vaccination to Prevent Infections of the Elderly
|
Phase 4 | |
| Withdrawn |
NCT04217252 -
Clinical Application of High-throughput Sequencing Technology for the Diagnosis of Patients With Severe Infection
|
N/A | |
| Recruiting |
NCT02899143 -
Short-course Antimicrobial Therapy in Sepsis
|
Phase 2 | |
| Recruiting |
NCT02905552 -
Myelodysplasic Syndromes and Risk Factors for Infection
|
N/A | |
| Withdrawn |
NCT02904434 -
Gastrointestinal Implications of Voriconazole Exposure
|
||
| Active, not recruiting |
NCT02768454 -
Antimicrobials Stewardship by Pharmacist
|
N/A | |
| Completed |
NCT02219776 -
Decreasing Infection In Arthroscopic Shoulder Surgery
|
N/A | |
| Completed |
NCT02210169 -
RCT of Continuous Versus Intermittent Infusion of Vancomycin in Neonates
|
N/A | |
| Recruiting |
NCT02098226 -
Evaluation of MALDI Biotyper CA System for Detection of Gram- and Gram+ Bacteria and Yeasts
|
N/A | |
| Completed |
NCT01846832 -
A Study of TMC435 Plus Pegylated Interferon Alfa-2a and Ribavirin in Participants With Chronic HCV Infection
|
Phase 3 | |
| Terminated |
NCT01441206 -
Safety and Pharmacokinetics of Single and Multiple Dose Rifampin in Infants
|
Phase 1 | |
| Completed |
NCT01434797 -
Value of PET/CT Imaging in the Diagnosis of Permanent Central Venous Catheters Infection
|
||
| Completed |
NCT01159834 -
Human Papillomavirus (HPV) Vaccination in Barretos (Pio XII Foundation - Barretos Cancer Hospital)
|
N/A |